Sacroiliitis and severe disability due to isotretinoin therapy

Rheumatol Int. 2010 May;30(7):985-6. doi: 10.1007/s00296-009-1014-4. Epub 2009 Jun 17.

Abstract

We report a case of acute sacroiliitis with severe disability after only 3 weeks of isotretinoin therapy with graduate reduction of pain, limitation and muscle incompetence after discontinuation of the drug and ACTH-depo injection and Ethodolac therapy. Naranjo probability scale indicated a probable relationship between isotretinoin therapy and bilateral sacroiliitis. We discussed possible mechanisms of sacroiliitis and disability due to isotretinoin treatment.

Publication types

  • Case Reports

MeSH terms

  • Acne Vulgaris / drug therapy
  • Adrenocorticotropic Hormone / therapeutic use
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthralgia / chemically induced*
  • Arthralgia / pathology
  • Arthralgia / physiopathology
  • Arthritis / chemically induced*
  • Arthritis / pathology
  • Arthritis / physiopathology
  • Dermatologic Agents / adverse effects*
  • Disability Evaluation
  • Edema / chemically induced
  • Edema / pathology
  • Etodolac / therapeutic use
  • Humans
  • Iatrogenic Disease / prevention & control
  • Isotretinoin / adverse effects*
  • Low Back Pain / chemically induced
  • Low Back Pain / pathology
  • Low Back Pain / physiopathology
  • Magnetic Resonance Imaging
  • Male
  • Muscle Weakness / etiology
  • Muscle Weakness / physiopathology
  • Radiography
  • Sacroiliac Joint / diagnostic imaging
  • Sacroiliac Joint / drug effects*
  • Sacroiliac Joint / pathology
  • Treatment Outcome
  • Whole Body Imaging / methods

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Dermatologic Agents
  • Etodolac
  • Adrenocorticotropic Hormone
  • Isotretinoin